Journal profile · Pharmacology, Toxicology and Pharmaceutics-Pharmacology
Current Pharmacogenomics and Personalized Medicine
ISSN 1875-6921 · eISSN 1875-6913 · Bentham
Current Pharmacogenomics and Personalized Medicine: subscription journal; median 92 days to acceptance (88 articles, last 24 months); 33 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Current Pharmacogenomics and Personalized Medicine is published by Bentham. By OpenAlex counts of its recent articles, its largest topics are Pharmacogenetics and Drug Metabolism, Genetic Associations and Epidemiology and Nutrition, Genetics, and Disease, together about 51.6% of its articles. Its main subfields are Genetics. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Pharmacology, Toxicology and Pharmaceutics-Pharmacology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics27.6%
- Genetic Associations and EpidemiologyBiochemistry, Genetics and Molecular Biology14.9%
- Nutrition, Genetics, and DiseaseBiochemistry, Genetics and Molecular Biology9.2%
- Computational Drug Discovery MethodsComputer Science4.4%
- Race, Genetics, and SocietyBiochemistry, Genetics and Molecular Biology3.4%
- Bioinformatics and Genomic NetworksBiochemistry, Genetics and Molecular Biology3.2%
- Science, Research, and MedicineMedicine3.2%
- Drug Transport and Resistance MechanismsMedicine2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pharmacology | Q4 | 294/328 | — |
| Genetics (clinical) | Q4 | 93/100 | — |
| Molecular Medicine | Q4 | 173/179 | — |
| Genetics | Q4 | 350/357 | — |
| Molecular Biology | Q4 | 407/414 | — |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.5LetPub ·
- SJR 2026-06
- 0.18LetPub ·
- SNIP 2026-06
- 0.26LetPub ·
- h-index
- 23OpenAlex ·
- i10-index
- 65OpenAlex ·
- 2-year mean citedness
- 0.42OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 514 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 70 | 0 | 98 |
| 2025 | 33 | 3 | 146 |
| 2024 | 21 | 2 | 130 |
| 2023 | 18 | 2 | 148 |
| 2022 | 14 | 1 | 140 |
| 2021 | 18 | 1 | 157 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
92 daysMedian, submission to acceptance · P25–P75 75 days – 112 days
- Acceptance to online
- median 166 days (88 articles)
- Submission to online
- median 264 days
- Sample
- 88 articles with submission and acceptance dates (105 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Bentham
- ISSN
- 1875-6921
- Electronic ISSN
- 1875-6913
FAQ
Frequently asked questions about Current Pharmacogenomics and Personalized Medicine
How long does peer review take at Current Pharmacogenomics and Personalized Medicine?
Based on the dates recorded on 88 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 92 days (interquartile range 75–112 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Current Pharmacogenomics and Personalized Medicine?
According to LetPub and DOAJ records, Current Pharmacogenomics and Personalized Medicine is indexed in Scopus.
Is Current Pharmacogenomics and Personalized Medicine open access, and what is the APC?
Current Pharmacogenomics and Personalized Medicine is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .